Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5062)
All Articles published online
|
Feb 14, 2012 (publication date) through Jan 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hao XW, Zhu ST, He YL, Li P, Wang YJ, Zhang ST. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma. World J Gastroenterol 2012; 18(6): 532-540 [PMID: 22363119 DOI: 10.3748/wjg.v18.i6.532] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i6/532.htm |
| Number | Citing Articles |
| 1 |
Li Shang, Mingrong Wang. Molecular alterations and clinical relevance in esophageal squamous cell carcinoma. Frontiers of Medicine 2013; 7(4): 401 doi: 10.1007/s11684-013-0286-y
|
| 2 |
The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819877977
|
| 3 |
Hongxiao Wang, Zijun Song, Enjun Xie, Junyi Chen, Biyao Tang, Fudi Wang, Junxia Min. Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell Carcinoma. Research 2022; 2022 doi: 10.34133/2022/9814652
|
| 4 |
Raghibul Hasan, Gunjan Srivastava, Akram Alyass, Rinu Sharma, Anoop Saraya, Tushar K. Chattopadhyay, Siddartha DattaGupta, Paul G. Walfish, Shyam S. Chauhan, Ranju Ralhan. Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model. Oncotarget 2022; 13(1): 1020 doi: 10.18632/oncotarget.10656
|
| 5 |
Xiao‐Song Ge, Hua‐Juan Ma, Xiao‐Hui Zheng, Hong‐Lian Ruan, Xiao‐Yu Liao, Wen‐Qiong Xue, Yuan‐Bin Chen, Ying Zhang, Wei‐Hua Jia. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF‐1 expression and activates Wnt pathway. Cancer Science 2013; 104(12): 1675 doi: 10.1111/cas.12296
|
| 6 |
Yasushi Toh, Akinori Egashira, Manabu Yamamoto, Shohei Yamaguchi. Interplay among epigenetic alterations and crosstalk between genetic and epigenetic alterations in esophageal squamous cell carcinoma. Esophagus 2014; 11(3): 162 doi: 10.1007/s10388-014-0431-y
|
| 7 |
Jun Yu, Yang Xie, Mengying Li, Fenfang Zhou, Zhenyang Zhong, Yuting Liu, Feng Wang, Jian Qi. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10709
|
| 8 |
Vanessa Ortiz-Barahona, Ricky S. Joshi, Manel Esteller. Use of DNA methylation profiling in translational oncology. Seminars in Cancer Biology 2022; 83: 523 doi: 10.1016/j.semcancer.2020.12.011
|
| 9 |
Long Liao, Zi‐Ting Yao, Wang‐Kai Fang, Qing‐Yu He, Wen Wen Xu, Bin Li. Epigenetics in Esophageal Cancer: From Mechanisms to Therapeutics. Small Methods 2020; 4(10) doi: 10.1002/smtd.202000391
|
| 10 |
Pere Llinàs-Arias, Manel Esteller. Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update. Open Biology 2017; 7(9): 170152 doi: 10.1098/rsob.170152
|
| 11 |
Fatemeh Ardalan Moghadam Al, Mohammad Mahdi Forghanifard, Vajiheh Zarrinpour. PYGO2 increases proliferation and migration capacities through critical signaling pathways in esophageal squamous cell carcinoma. Journal of Biochemical and Molecular Toxicology 2024; 38(1) doi: 10.1002/jbt.23625
|
| 12 |
Yu Lian, Xiangdong Niu, Hui Cai, Xiaojun Yang, Haizhong Ma, Shixun Ma, Yupeng Zhang, Yifeng Chen. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma. Tumor Biology 2017; 39(7): 101042831771580 doi: 10.1177/1010428317715804
|